We are live on ! Find out more
BGCP

Bristol Gate Capital Partners Portfolio holdings

AUM $1.55B
1-Year Est. Return 12.75%
This Fund
S&P 500
This Quarter Est. Return
+1.64%
1 Year Est. Return
+12.75%
3 Year Est. Return
+56.06%
5 Year Est. Return
+77.57%
10 Year Est. Return
+291.67%
AUM
$2.05B
AUM Growth
-$5.96M
Cap. Flow
+$2.98M
Cap. Flow %
0.15%
Top 10 Hldgs %
50.68%
Holding
36
New
3
Increased
11
Reduced
17
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$98.4M
2
WAB icon
Wabtec
WAB
+$93.8M
3
DPZ icon
Domino's
DPZ
+$90.7M
4
MCHP icon
Microchip Technology
MCHP
+$26M
5
AMAT icon
Applied Materials
AMAT
+$24.5M

Top Sells

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$98.1M
2
LOW icon
Lowe's Companies
LOW
+$89.5M
3
CSX icon
CSX Corp
CSX
+$79.3M
4
AVGO icon
Broadcom
AVGO
+$19.5M
5
MSCI icon
MSCI
MSCI
+$17.7M

Sector Composition

Rank Sector Weight
1 Financials 24.75%
2 Healthcare 23.37%
3 Industrials 22.65%
4 Technology 19.48%
5 Materials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRI icon
26
Thomson Reuters
TRI
$47.6B
$995K 0.05%
5,676
-621
-10% -$107K
FSV icon
27
FirstService
FSV
$6.21B
$991K 0.05%
5,978
-651
-10% -$114K
CIGI icon
28
Colliers International
CIGI
$5.06B
$914K 0.04%
7,554
-788
-9% -$103K
OTEX icon
29
Open Text
OTEX
$6.41B
$811K 0.04%
32,135
-3,532
-10% -$96.9K
CNI icon
30
Canadian National Railway
CNI
$77B
$798K 0.04%
8,206
-902
-10% -$91.2K
TFII icon
31
TFI International
TFII
$11.6B
$603K 0.03%
7,793
-858
-10% -$94.9K
SPGI icon
32
S&P Global
SPGI
$122B
$356K 0.02%
700
CSX icon
33
CSX Corp
CSX
$94.5B
-2,457,257
Closed -$79.3M
CTVA icon
34
Corteva
CTVA
$52.2B
-1,722,139
Closed -$98.1M
LOW icon
35
Lowe's Companies
LOW
$122B
-362,473
Closed -$89.5M
MATX icon
36
Matsons
MATX
$6.46B
-1,500
Closed -$202K

Similar funds

Bristol Gate Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Bristol Gate Capital Partners held 36 positions worth $2.05B, down 0.29% from $2.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Bristol Gate Capital Partners's Q1 2025 filing shows 3 new, 11 increased, 17 reduced and 4 closed positions. Its largest new stake was Eli Lilly: 118,275 shares worth $97.7M. The largest sale was Corteva, an estimated $98.1M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Bristol Gate Capital Partners's largest Q1 2025 buy was Eli Lilly: 118,275 shares worth $97.7M.
  • Bristol Gate Capital Partners added most to Microchip Technology in Q1 2025, an estimated $26M increase.
  • Bristol Gate Capital Partners's biggest Q1 2025 reduction was Broadcom, cutting an estimated $19.5M.
  • Bristol Gate Capital Partners fully exited Corteva in Q1 2025, selling an estimated $98.1M.
  • Bristol Gate Capital Partners's ten largest holdings make up 51% of its $2.05B portfolio in Q1 2025.
  • Bristol Gate Capital Partners opened 3 new positions and closed 4 in Q1 2025.
  • Bristol Gate Capital Partners's portfolio value fell 0.29% quarter-over-quarter to $2.05B.

Based on Bristol Gate Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.